Home > Healthcare > Medical Devices > Therapeutic Devices > spine bone stimulators market
Get a free sample of Spine Bone Stimulators Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Spine Bone Stimulators Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Research and utilization of advanced materials, coupled with the incorporation of electromagnetic fields, have led to significant advancements in bone growth stimulator devices. These advancements have resulted in higher efficacy and additional advantages, consequently fuelling the demand for spine bone stimulators in the market.
Non-invasive spine bone stimulator segment held leading revenue share in 2023 and is anticipated to reach USD 834 million by 2032, driven by their safer, more comfortable, and convenient nature compared to invasive surgical procedures.
Global spine bone stimulators industry was valued at around USD 661.7 million in 2023 and is expected to reach around USD 1.11 billion by 2032, driven by a consistent increase in spinal deformities.
North America spine bone stimulators market accounted for USD 368.4 million in 2023 and will record notable growth over 2024 and 2032, driven by greater awareness among patients and healthcare providers in the region about spinal deformity.
Bioventus, Elizur Corporation, Enovis (DJO Global, Inc.), IGEA S.p.A., Medtronic plc, Orthofix Medical Inc., Ossatec Benelux BV, Synergy Orthopedics, Theragen, Inc. (Neurotech NA Inc.) are some of the major industry contenders.